Dock2 participates in bone marrow lympho-hematopoiesis

Tomoko Kikuchi, Shiro Kubonishi, Misako Shibakura, Noriko Namba, Toshimitsu Matsui, Yoshinori Fukui, Mitsune Tanimoto, Yoshio Katayama

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Dock2 has been shown to be indispensable for chemotaxis of mature lymphocytes as a critical Rac activator. However, the functional expression of Dock2 in immature hematopoietic cells is unclear. In this study, we demonstrate that Dock2 is broadly expressed in bone marrow (BM) hematopoietic compartment, including hematopoietic stem/progenitor cell (HSC/HPC) fraction. Response of Dock2-/- HPCs to CXCL12 in chemotaxis and actin polymerization in vitro was impaired, although α4 integrin activation by CXCL12 was not altered. Myelosuppressive stress on HSCs in vivo, such as consecutive 5-FU administration and serial bone marrow transplantation, did not show hematopoietic defect in Dock2-/- mice. Long-term engraftment of transplanted Dock2-/- BM cells was severely impaired in competitive reconstitution. However, this was not intrinsic to HSCs but originated from the defective competition of Dock2-/- lymphoid precursors. These results suggest that Dock2 plays a significant role in BM lymphopoiesis, but is dispensable for HSC engraftment and self-renewal.

Original languageEnglish
Pages (from-to)90-96
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume367
Issue number1
DOIs
Publication statusPublished - Feb 29 2008

Fingerprint

Hematopoiesis
Chemotaxis
Hematopoietic Stem Cells
Bone
Bone Marrow
Lymphopoiesis
Bone Marrow Transplantation
Integrins
Fluorouracil
Polymerization
Bone Marrow Cells
Actins
Lymphocytes
Stem cells
Chemical activation
Defects
In Vitro Techniques

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

Kikuchi, T., Kubonishi, S., Shibakura, M., Namba, N., Matsui, T., Fukui, Y., ... Katayama, Y. (2008). Dock2 participates in bone marrow lympho-hematopoiesis. Biochemical and Biophysical Research Communications, 367(1), 90-96. https://doi.org/10.1016/j.bbrc.2007.12.093

Dock2 participates in bone marrow lympho-hematopoiesis. / Kikuchi, Tomoko; Kubonishi, Shiro; Shibakura, Misako; Namba, Noriko; Matsui, Toshimitsu; Fukui, Yoshinori; Tanimoto, Mitsune; Katayama, Yoshio.

In: Biochemical and Biophysical Research Communications, Vol. 367, No. 1, 29.02.2008, p. 90-96.

Research output: Contribution to journalArticle

Kikuchi, T, Kubonishi, S, Shibakura, M, Namba, N, Matsui, T, Fukui, Y, Tanimoto, M & Katayama, Y 2008, 'Dock2 participates in bone marrow lympho-hematopoiesis', Biochemical and Biophysical Research Communications, vol. 367, no. 1, pp. 90-96. https://doi.org/10.1016/j.bbrc.2007.12.093
Kikuchi, Tomoko ; Kubonishi, Shiro ; Shibakura, Misako ; Namba, Noriko ; Matsui, Toshimitsu ; Fukui, Yoshinori ; Tanimoto, Mitsune ; Katayama, Yoshio. / Dock2 participates in bone marrow lympho-hematopoiesis. In: Biochemical and Biophysical Research Communications. 2008 ; Vol. 367, No. 1. pp. 90-96.
@article{2865d7009e424e53b6e308db2906da16,
title = "Dock2 participates in bone marrow lympho-hematopoiesis",
abstract = "Dock2 has been shown to be indispensable for chemotaxis of mature lymphocytes as a critical Rac activator. However, the functional expression of Dock2 in immature hematopoietic cells is unclear. In this study, we demonstrate that Dock2 is broadly expressed in bone marrow (BM) hematopoietic compartment, including hematopoietic stem/progenitor cell (HSC/HPC) fraction. Response of Dock2-/- HPCs to CXCL12 in chemotaxis and actin polymerization in vitro was impaired, although α4 integrin activation by CXCL12 was not altered. Myelosuppressive stress on HSCs in vivo, such as consecutive 5-FU administration and serial bone marrow transplantation, did not show hematopoietic defect in Dock2-/- mice. Long-term engraftment of transplanted Dock2-/- BM cells was severely impaired in competitive reconstitution. However, this was not intrinsic to HSCs but originated from the defective competition of Dock2-/- lymphoid precursors. These results suggest that Dock2 plays a significant role in BM lymphopoiesis, but is dispensable for HSC engraftment and self-renewal.",
author = "Tomoko Kikuchi and Shiro Kubonishi and Misako Shibakura and Noriko Namba and Toshimitsu Matsui and Yoshinori Fukui and Mitsune Tanimoto and Yoshio Katayama",
year = "2008",
month = "2",
day = "29",
doi = "10.1016/j.bbrc.2007.12.093",
language = "English",
volume = "367",
pages = "90--96",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Dock2 participates in bone marrow lympho-hematopoiesis

AU - Kikuchi, Tomoko

AU - Kubonishi, Shiro

AU - Shibakura, Misako

AU - Namba, Noriko

AU - Matsui, Toshimitsu

AU - Fukui, Yoshinori

AU - Tanimoto, Mitsune

AU - Katayama, Yoshio

PY - 2008/2/29

Y1 - 2008/2/29

N2 - Dock2 has been shown to be indispensable for chemotaxis of mature lymphocytes as a critical Rac activator. However, the functional expression of Dock2 in immature hematopoietic cells is unclear. In this study, we demonstrate that Dock2 is broadly expressed in bone marrow (BM) hematopoietic compartment, including hematopoietic stem/progenitor cell (HSC/HPC) fraction. Response of Dock2-/- HPCs to CXCL12 in chemotaxis and actin polymerization in vitro was impaired, although α4 integrin activation by CXCL12 was not altered. Myelosuppressive stress on HSCs in vivo, such as consecutive 5-FU administration and serial bone marrow transplantation, did not show hematopoietic defect in Dock2-/- mice. Long-term engraftment of transplanted Dock2-/- BM cells was severely impaired in competitive reconstitution. However, this was not intrinsic to HSCs but originated from the defective competition of Dock2-/- lymphoid precursors. These results suggest that Dock2 plays a significant role in BM lymphopoiesis, but is dispensable for HSC engraftment and self-renewal.

AB - Dock2 has been shown to be indispensable for chemotaxis of mature lymphocytes as a critical Rac activator. However, the functional expression of Dock2 in immature hematopoietic cells is unclear. In this study, we demonstrate that Dock2 is broadly expressed in bone marrow (BM) hematopoietic compartment, including hematopoietic stem/progenitor cell (HSC/HPC) fraction. Response of Dock2-/- HPCs to CXCL12 in chemotaxis and actin polymerization in vitro was impaired, although α4 integrin activation by CXCL12 was not altered. Myelosuppressive stress on HSCs in vivo, such as consecutive 5-FU administration and serial bone marrow transplantation, did not show hematopoietic defect in Dock2-/- mice. Long-term engraftment of transplanted Dock2-/- BM cells was severely impaired in competitive reconstitution. However, this was not intrinsic to HSCs but originated from the defective competition of Dock2-/- lymphoid precursors. These results suggest that Dock2 plays a significant role in BM lymphopoiesis, but is dispensable for HSC engraftment and self-renewal.

UR - http://www.scopus.com/inward/record.url?scp=38049129792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049129792&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2007.12.093

DO - 10.1016/j.bbrc.2007.12.093

M3 - Article

C2 - 18157938

AN - SCOPUS:38049129792

VL - 367

SP - 90

EP - 96

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 1

ER -